0001493152-16-016310.txt : 20161230 0001493152-16-016310.hdr.sgml : 20161230 20161230143356 ACCESSION NUMBER: 0001493152-16-016310 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 EFFECTIVENESS DATE: 20161230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Imprimis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-277423 FILM NUMBER: 162077411 BUSINESS ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4042 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 D 1 primary_doc.xml X0707 D LIVE 0001360214 Imprimis Pharmaceuticals, Inc. 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA CALIFORNIA 92130 858-704- 4040 DELAWARE Transdel Pharmaceuticals, Inc. Bywater Resources, Inc. TRANSDEL PHARMACEUTICALS INC Bywater Resources, Inc Corporation true Mark Baum 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Executive Officer Director Andrew Boll 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Executive Officer Robert Kammer 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Richard Lindstrom 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Stephen Austin 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Anthony Principi 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2016-12-27 false true true false 0 National Securities Corporation 7569 None None 410 PARK AVENUE NEW YORK NY NEW YORK 10022 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN false 10068740 10068740 0 false 143 755155 0 Recipient also received a warrant to purchase up to 210,313 shares of the Issuer's common stock. 0 false Imprimis Pharmaceuticals, Inc. /s/ Andrew Boll Andrew Boll Chief Financial Officer 2016-12-30